Paragon 28 Stock Today
| FNA Stock | USD 9.99 0.01 0.10% |
Performance5 of 100
| Odds Of DistressLess than 28
|
Paragon 28 is trading at 9.99 as of the 28th of November 2024, a 0.10 percent increase since the beginning of the trading day. The stock's open price was 9.98. Paragon 28 has about a 28 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Note, on August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Paragon 28's common stock.
Business Domain Health Care Equipment & Services | IPO Date 15th of October 2021 | Category Healthcare | Classification Health Care |
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. Paragon 28 operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 83.72 M outstanding shares of which 4.52 M shares are currently shorted by investors with about 6.27 days to cover. More on Paragon 28
Moving together with Paragon Stock
Moving against Paragon Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Paragon Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Albert DaCosta | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Medical Equipment (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [FIRST NIAGARA FINL, FIRST NIAGARA FINL - Frankfurt Stock Exchang] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsParagon 28 can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Paragon 28's financial leverage. It provides some insight into what part of Paragon 28's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Paragon 28 (FNA) is traded on New York Stock Exchange in USA. It is located in 14445 Grasslands Drive, Englewood, CO, United States, 80112 and employs 574 people. Paragon 28 is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 835.53 M. Paragon 28 runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 83.72 M outstanding shares of which 4.52 M shares are currently shorted by investors with about 6.27 days to cover.
Paragon 28 has about 73 M in cash with (63.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check Paragon 28 Probability Of Bankruptcy
Ownership AllocationParagon 28 owns a total of 83.72 Million outstanding shares. Over half of Paragon 28's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Also note that almost one million two hundred sixty-four thousand one hundred seventy-seven invesors are currently shorting Paragon 28 expressing very little confidence in its future performance.
Check Paragon Ownership Details
Paragon Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-09-30 | 967.5 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 963.3 K | |
| Bank Of America Corp | 2024-06-30 | 750.9 K | |
| Eversept Partners, Llc | 2024-09-30 | 749.2 K | |
| Millennium Management Llc | 2024-06-30 | 725.5 K | |
| Thrivent Financial For Lutherans | 2024-09-30 | 674.5 K | |
| Wellington Management Company Llp | 2024-06-30 | 649.6 K | |
| Park Edge Advisors, Llc | 2024-09-30 | 598.9 K | |
| Peregrine Capital Management,llc | 2024-09-30 | 491 K | |
| Mvm Partners Llc | 2024-09-30 | 10.9 M | |
| First Light Asset Management, Llc | 2024-09-30 | 10.2 M |
Paragon 28 Historical Income Statement
Paragon Stock Against Markets
Paragon 28 Corporate Management
| Matthew Jarboe | Executive Officer | Profile | |
| B Johnson | Director | Profile | |
| Matthew Brinckman | Senior Relations | Profile | |
| Matt Jarboe | Chief Commercial Officer | Profile | |
| Matt Brinckman | Senior Relations | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Paragon 28. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Paragon Stock refer to our How to Trade Paragon Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Paragon 28. If investors know Paragon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Paragon 28 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share 2.95 | Quarterly Revenue Growth 0.181 | Return On Assets (0.08) | Return On Equity (0.34) |
The market value of Paragon 28 is measured differently than its book value, which is the value of Paragon that is recorded on the company's balance sheet. Investors also form their own opinion of Paragon 28's value that differs from its market value or its book value, called intrinsic value, which is Paragon 28's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Paragon 28's market value can be influenced by many factors that don't directly affect Paragon 28's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Paragon 28's value and its price as these two are different measures arrived at by different means. Investors typically determine if Paragon 28 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Paragon 28's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.